Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTC-Guided Adjuvant Therapy in Colorectal Cancer
NCT05424692Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2025
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of fluorouracil, folinic acid, oxaliplatin, irinotecan and cetuximab in colorectal cancer (CRC), sponsored by Peking Union Medical College Hospital. Started Sep 2021; status: recruiting.
02
Drugs
fluorouracilfolinic acidoxaliplatinirinotecancetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05424692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05424692.